
Glimstin M 1mg/500mg Tablet SR
Marketer
Tulsi Medi Sciences
Salt Composition
Glimepiride (1mg) + Metformin (500mg)
Overview Glimstin M 1mg/500mg Tablet SR
Diabetol Duo 1mg/500mg Extended-Release tablets are classified as antidiabetic medications. This dual-action formulation treats type 2 diabetes in adults by regulating blood glucose. Diabetol Duo should be ingested with food, consistently at the same time daily for optimal efficacy. Dosage is determined and adjusted by your physician based on your blood sugar response. Continued use is crucial, even with controlled blood sugar, as discontinuation without medical supervision can lead to elevated glucose levels and potentially serious complications including kidney impairment, vision loss, neuropathy, and limb loss. Remember, this medication complements a comprehensive diabetes management plan encompassing a balanced diet, regular physical activity, and weight management as directed by your doctor. Lifestyle choices significantly impact diabetes control. Hypoglycemia (low blood sugar) is a prevalent side effect, characterized by symptoms like sweating, dizziness, headache, and tremors. Regular meals and readily available glucose sources (e.g., sugary snacks, fruit juice) are essential for prevention. Alcohol consumption increases hypoglycemia risk and should be limited. Additional potential side effects include altered taste perception, nausea, diarrhea, abdominal discomfort, headache, and upper respiratory infections. Weight gain may also occur. This medication is contraindicated in individuals with type 1 diabetes, diabetic ketoacidosis, or severe hepatic or renal impairment. Prior heart disease should be disclosed to your physician before commencing treatment. Pregnant or lactating women require medical consultation before use. Regular blood glucose monitoring and periodic blood tests (complete blood count and liver function tests) are recommended as directed by your physician.
Primary Ingredients of Glimstin M 1mg/500mg Tablet SR
No text provided to rephrase.
Uses of Glimstin M 1mg/500mg Tablet SR
Managing type 2 diabetes
Major Benefits of Glimstin M 1mg/500mg Tablet SR:
Consume this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment length. Ingest the Glimstin M 1mg/500mg Tablet SR whole; avoid chewing, crushing, or fracturing it. Administer this medication with a meal.
Common Side effects of Glimstin M 1mg/500mg Tablet SR:
- Headache
- Hypoglycemia (low blood glucose level)
- Nausea
- Diarrhea
How to use Glimstin M 1mg/500mg Tablet SR:
Follow your physician's instructions precisely regarding dosage and treatment length for this medication. Ingest the Glimstin M 1mg/500mg Tablet SR whole; do not fracture, pulverize, or chew. Administer this extended-release tablet with a meal.
How Glimstin M 1mg/500mg Tablet SR works:
Glimstin M SR tablets (1mg glimepiride/500mg metformin) combine two antidiabetic agents. Glimepiride, a sulfonylurea, stimulates pancreatic insulin secretion to reduce blood sugar. Metformin, a biguanide, acts by decreasing hepatic glucose production, slowing intestinal glucose absorption, and enhancing insulin sensitivity.
SAFETY ADVICE
AlcoholUNSAFE
Concurrent alcohol and Glimstin M 1mg/500mg Tablet SR use poses a safety risk.
PregnancyCONSULT YOUR DOCTOR
The extended-release Glimstin M 1mg/500mg tablet might pose risks during pregnancy. While human data is scarce, animal research indicates potential harm to a developing fetus. A physician will assess the potential advantages against any possible hazards prior to prescribing. Seek medical advice.
Breast feedingUNSAFE
Prolonged-release Glimstin M 1mg/500mg tablets are contraindicated for breastfeeding mothers. Evidence indicates potential infant toxicity from this medication.
DrivingCAUTION
Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these conditions.
KidneyCAUTION
Exercise caution when administering Glimstin M 1mg/500mg Tablet SR to individuals with impaired renal function; dosage modification may be necessary. Consult a physician for guidance. In patients exhibiting severe kidney disease, Glimstin M 1mg/500mg Tablet SR is contraindicated. Close monitoring of kidney function is recommended during treatment.
LiverCAUTION
Patients with liver impairment should use Glimstin M 1mg/500mg Tablet SR cautiously, potentially requiring dosage modification. Consult a physician. A reduced initial dose is typically prescribed for those with mild to moderate liver disease; however, its use is contraindicated in cases of severe hepatic dysfunction.
What if you forget to take Glimstin M 1mg/500mg Tablet SR :
Should you forget to take a Glimstin M 1mg/500mg Tablet SR, administer it at your earliest convenience. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Glimstin M 1mg/500mg Tablet SR
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Diabetes Management |
